Archive - July 2018
Want to make a difference? Enter the new Charity Challenge
Fly your company’s flag – ENTER NOW
Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
Sub-cutaneous form of Entyvio hits PhIII safety, efficacy goals
Kisqali wins speedy US breast cancer nod
Four pharmas named for breaching ABPI Code of Practice
Dementia accounts for 12.7 percent of deaths
Novartis bags rights to Galapagos/MorphoSys atopic dermatitis drug